Here’s a simple guide on who can get them, how they protect against current virus strains, and what to know about insurance.

The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and mNexspike ®. The updated mRNA vaccines target the LP.8.1 variant of ...

CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug ...

Under the CDC's current list of high-risk conditions, "almost everyone who wanted to receive a vaccine could," William ...

The Food and Drug Administration (FDA) on Wednesday approved the updated version of Pfizer’s and Moderna’s COVID-19 vaccines for this upcoming respiratory viral season, but limited the approval to ...

The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated ...

Moderna announced on Wednesday it has completed its submission to the US Food and Drug Administration for full approval of its COVID-19 vaccine for people age 18 and older, and Pfizer and BioNTech ...

Moderna announced the Food and Drug Administration has approved the supplemental Biologics License Applications (sBLA) for the 2025-2026 formulas for Spikevax and mNEXSPIKE, targeting the LP.8.1 ...

WASHINGTON -- Moderna is applying for full government approval for its COVID-19 vaccine. The company said it is submitting trial data to the Food and Drug Administration on a rolling basis over the ...

The report says officials plan to include the claim in a presentation next week to a key vaccine panel that advises the CDC ...